RecruitingPHASE1, PHASE2NCT05462106
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Studying Down syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AC Immune SA
- Principal Investigator
- Michael Rafii, MDUniversity of Southern California, Alzheimer's Therapeutic Research Institute, 9860 Mesa Rim Rd, San Diego, CA 92121, USA
- Intervention
- Placebo(biological)
- Enrollment
- 176 enrolled
- Eligibility
- 35-85 years · All sexes
- Timeline
- 2022 – 2026
Study locations (19)
- Barrow Neurological Institute, Phoenix, Arizona, United States
- Indiana University / IU Health, Indianapolis, Indiana, United States
- University of Kansas Medical Center Research Institute, Fairway, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- The Washington University, St Louis, Missouri, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- UT Health San Antonio, San Antonio, Texas, United States
- Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Hospital Universitario Virgen De Las Nieves, Granada, Spain
- Hospital Clínico San Carlos, Madrid, Spain
- Hospital Universitario de la Princesa, Madrid, Spain
- Hospital Universitario Marqués de Valdecilla, Santander, Spain
- Hospital Universitario y Politécnico La Fe, Valencia, Spain
- Cambridge and Peterborough NHS Foundation Trust - Windsor Research Units, Cambridge, United Kingdom
- +4 more locations on ClinicalTrials.gov
Collaborators
Worldwide Clinical Trials
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05462106 on ClinicalTrials.govOther trials for Down syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07416201Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without ThymectomyNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT07484464Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down SyndromeRiphah International University
- RECRUITINGNANCT07296861HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down SyndromeUNC Lineberger Comprehensive Cancer Center
- RECRUITINGNCT07195253Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down SyndromeHospices Civils de Lyon
- ENROLLING BY INVITATIONNCT07413224Qualitative Effects of AEF0217 in Down Syndrome PeopleAelis Farma
- RECRUITINGPHASE4NCT07280468Endotype DIrected Treatment for OSA in Down SyndromeUniversity of Arizona
- RECRUITINGNANCT07425769Adapting RDAD for DSUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07242638Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeIcahn School of Medicine at Mount Sinai